Breaking News Instant updates and real-time market news.

WLK

Westlake Chemical

$106.62

-0.575 (-0.54%)

, MTD

Mettler-Toledo

$558.45

3.19 (0.57%)

10:34
04/09/18
04/09
10:34
04/09/18
10:34

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Westlake Chemical (WLK) downgraded to Neutral from Overweight at JPMorgan with analyst Jeffrey Zekauskas citing valuation. 2. Mettler-Toledo (MTD) downgraded to Neutral from Buy at Goldman Sachs with analyst Patrick Donnelly saying he sees an attractive fundamental backdrop across Tools but is more cautious on the outlook for sales upside at Mettler given his view of a likely moderation of growth in China after a year of catch-up investment in the region. Donnelly also highlights "tough comps" in Labs and Product inspection. 3. Franklin Resources (BEN) downgraded to Neutral from Buy at BofA/Merrill with analyst Michael Carrier saying Franklin's bottom half performance and continued outflows limits organic growth and multiple expansion. 4. NewLink Genetics (NLNK) downgraded to Neutral from Overweight at Cantor Fitzgerald and Baird as well as to Hold from Buy at Jefferies. 5. Incyte (INCY) downgraded to Hold from Buy at Gabelli with analyst Jing He citing the "surprising" failure of the Phase 3 ECHO-301 study in melanoma. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

WLK

Westlake Chemical

$106.62

-0.575 (-0.54%)

MTD

Mettler-Toledo

$558.45

3.19 (0.57%)

BEN

Franklin Resources

$33.12

-0.1 (-0.30%)

NLNK

NewLink Genetics

$4.20

-3.12 (-42.62%)

INCY

Incyte

$64.02

-19.05 (-22.93%)

  • 23

    Apr

  • 08

    May

  • 12

    Jun

WLK Westlake Chemical
$106.62

-0.575 (-0.54%)

02/21/18
SBSH
02/21/18
NO CHANGE
Target $133
SBSH
Buy
Westlake Chemical price target raised to $133 from $125 at Citi
Citi analyst P.J. Juvekar raised his price target for Westlake Chemical to $133 citing the upcycles in chlor alkali and vinyls. Vinyls continues on an upward trajectory helped by an improving chlor alkali cycle, chlorine capacity shutdowns in Europe, China environmental regulations and improved utilization of the acquired Axiall assets, Juvekar tells investors in a research note. The analyst reiterates a Buy rating on Westlake.
03/27/18
BMOC
03/27/18
INITIATION
Target $125
BMOC
Market Perform
Westlake Chemical initiated with a Market Perform at BMO Capital
BMO Capital analyst John McNulty started Westlake Chemical with a Market Perform rating and $125 price target.
03/28/18
BMOC
03/28/18
INITIATION
Target $125
BMOC
Market Perform
Westlake Chemical initiated with a Market Perform at BMO Capital
As reported earlier, BMO Capital analyst John McNulty initiated Westlake Chemical with a Market Perform rating and a price target of $125. McNulty says the company offers an opportunity to invest in the current Chlor-Alkali upcycle, adding that he is also positive on Westlake's integrated nature of Olefins and Vinyls business segments. Based on the early 2018 outperformance, McNulty states that he has a more cautious near-term approach on the stock.
04/09/18
JPMS
04/09/18
DOWNGRADE
Target $110
JPMS
Neutral
Westlake Chemical downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Westlake Chemical to Neutral while raising his price target for the shares to $110 from $104. The analyst cites valuation for the downgrade and believes new ethylene and polyethylene capacity is likely slow EBITDA growth and bring margin pressure. He does not see Westlake shares outperforming over the next year.
MTD Mettler-Toledo
$558.45

3.19 (0.57%)

04/09/18
GSCO
04/09/18
UPGRADE
Target $77
GSCO
Buy
Goldman upgrades Agilent to Buy ahead of Q1 earnings season
Goldman Sachs analyst Patrick Donnelly upgraded Agilent Technologies (A) to Buy from Neutral and raised his price target for the shares to $77 from $73. Heading into the Q1 earnings season, the analyst sees an attractive fundamental backdrop across Tools. He believes, however, that the favorable backdrop is well understood by investors with valuations that "remain well-above 10-year highs." The analyst prefers the "idiosyncratic drivers of growth" for Agilent in the out years and views the stock's relative valuation as attractive. He coupled the upgrade with a downgrade of Mettler-Toledo (MTD) to Neutral.
04/09/18
GSCO
04/09/18
DOWNGRADE
Target $600
GSCO
Neutral
Goldman downgrades Mettler-Toledo to Neutral ahead of Q1 earnings
Goldman Sachs analyst Patrick Donnelly downgraded Mettler-Toledo (MTD) to Neutral from Buy and cut his price target for the shares to $600 from $725. Heading into the Q1 earnings season, the analyst sees an attractive fundamental backdrop across Tools. He believes, however, that the favorable backdrop is well understood by investors with valuations that "remain well-above 10-year highs." The analyst is more cautious on the outlook for sales upside at Mettler given his view of a likely moderation of growth in China after a year of catch-up investment in the region. Donnelly also highlights "tough comps" in Labs and Product inspection. He coupled the downgrade with an upgrade of Agilent Technologies (A) to Buy.
04/09/18
GSCO
04/09/18
DOWNGRADE
GSCO
Neutral
Mettler-Toledo downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Patrick Donnell downgraded Mettler-Toledo to Neutral.
02/09/18
SBSH
02/09/18
UPGRADE
Target $692
SBSH
Buy
Mettler-Toledo upgraded to Buy from Neutral at Citi
Citi analyst Daniel Arias upgraded Mettler-Toledo to Buy and raised his price target for the shares to $692 from $685. The recent 13% selloff provides an opportunity to own a "best-in-class franchise with an excellent performance track record and relatively few business-related flaws," Arias tells investors in a research note. He expects the company's momentum in Q4 to carry into 2018.
BEN Franklin Resources
$33.12

-0.1 (-0.30%)

04/09/18
BOFA
04/09/18
DOWNGRADE
BOFA
Neutral
Franklin Resources downgraded to Neutral on weak performance at BofA/Merrill
As previously reported, As previously reported, BofA/Merrill downgraded Franklin Resources to Neutral from Buy and cut its price target to $37 from $50. Analyst Michael Carrier believes Franklin's bottom half performance and continued outflows limits organic growth and multiple expansion. Carrier lowered estimates given weaker Q1 markets, increased outflow expectations, and more muted 2018 return expectations.
04/09/18
BOFA
04/09/18
DOWNGRADE
BOFA
Neutral
Franklin Resources downgraded to Neutral from Buy at BofA/Merrill
04/05/18
FBCO
04/05/18
NO CHANGE
Target $34
FBCO
Underperform
Franklin Resources price target lowered to $34 from $39.57 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler lowered his price target for Franklin Resources to $34 from $57 on valuation. The analyst reiterates an Underperform rating on the shares.
09/08/17
LEHM
09/08/17
INITIATION
Target $40
LEHM
Underweight
Franklin Resources initiated with an Underweight at Barclays
Barclays analyst Jeremy Campbell started Franklin Resources with an Underweight rating and $40 price target. The analyst initiated U.S. Brokers, Asset Managers & Exchanges with a Neutral industry view.
NLNK NewLink Genetics
$4.20

-3.12 (-42.62%)

04/09/18
RHCO
04/09/18
DOWNGRADE
Target $5
RHCO
Hold
NewLink Genetics downgraded to Hold at SunTrust on Incyte trial failure
As reported late last week, SunTrust analyst Peter Lawson downgraded NewLink Genetics (NLNK) to Hold from Buy and lowered his price target to $5 from $19. Lawson cites the announcement of negative results from the Phase 3 ECHO-301 of epacadostat + Keytruda in melanoma by Incyte (INCY), saying the data also implies a "significant negative read through for NewLink's IDO agent, indoximod". Lawson adds that the results have led him to remove melanoma from his NewLink model and also reduce the probability of success in pancreatic cancer, lowering the probability of adjusted peak sales from $415M to just $11M.
04/09/18
CANT
04/09/18
DOWNGRADE
CANT
Neutral
NewLink Genetics downgraded to Neutral from Overweight at Cantor Fitzgerald
04/09/18
BARD
04/09/18
DOWNGRADE
Target $5
BARD
Neutral
NewLink Genetics downgraded to Neutral at Baird
As reported previously, Baird analyst Michael Ulz downgraded NewLink Genetics (NLNK) to Neutral from Outperform. The analyst cited the disappointing results from Incyte's (INCY) Phase-3 ECHO-301 study in melanoma. Given the uncertainty surrounding the opportunity after NewLink said it will revisit the indoximod clinical program following Incyte's news, Ulz lowered his price target to $5 from $22 on NewLink Genetics shares.
04/09/18
CANT
04/09/18
DOWNGRADE
Target $7
CANT
Neutral
Cantor downgrades NewLink with $7 target on added indoximod uncertainty
Cantor Fitzgerald analyst Mara Goldstein downgraded NewLink Genetics (NLNK) to Neutral from Overweight and cut her price target for the shares to $7 from $26. The analyst cites NewLink's decision to revisit the indoximod clinical program as the reason for the downgrade. Goldstein previously highlighted the differentiating factors between indoximod and Incyte's (INCY) epacadostat, but she now has reduced confidence given a "lack of decisive commentary" from NewLink management.
INCY Incyte
$64.02

-19.05 (-22.93%)

04/09/18
GABE
04/09/18
DOWNGRADE
GABE
Hold
Incyte downgraded to Hold from Buy at Gabelli
Gabelli analyst Jing He downgraded Incyte to Hold following the "surprising" failure of the Phase 3 ECHO-301 study in melanoma. The analyst remains positive on Jakafi's long-term growth and estimates peak sales of $2.7B but recommends staying on the sideline before baricitinib Adcom on April 23.
04/09/18
FBCO
04/09/18
NO CHANGE
Target $78
FBCO
Outperform
Incyte price target lowered to $78 from $145 at Credit Suisse
Credit Suisse analyst Alethia Young lowered her price target for Incyte to $78 from $145 following news on ECHO-301 and as she removes epacadostat from valuation. The analyst reiterates an Outperform rating on the shares.
04/09/18
RHCO
04/09/18
NO CHANGE
Target $80
RHCO
Buy
Incyte price target lowered to $80 from $155 at SunTrust
SunTrust analyst Peter Lawson slashed his price target on Incyte to $80 after the failure of phase 3 IDO study in melanoma, saying that he is removing all IDO indicators from his model while also sharply discounting the post-IDO pipeline. While the analyst warns that further negative news related to IDO readouts could be coming, the post-failure stock price decline does create some "underlying value", keeping his Buy rating on Incyte.

TODAY'S FREE FLY STORIES

VLKAY

Volkswagen

$0.00

(0.00%)

, WMT

Walmart

$97.89

-0.74 (-0.75%)

19:37
08/19/18
08/19
19:37
08/19/18
19:37
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

VLKAY

Volkswagen

$0.00

(0.00%)

WMT

Walmart

$97.89

-0.74 (-0.75%)

MSFT

Microsoft

$107.58

-0.07 (-0.07%)

TCEHY

Tencent

$0.00

(0.00%)

STT

State Street

$84.95

0.73 (0.87%)

TWX

Acquired by T

$0.00

(0.00%)

KSS

Kohl's

$76.43

1.68 (2.25%)

BV

BrightView

$17.49

-0.06 (-0.34%)

VZ

Verizon

$54.79

0.51 (0.94%)

ABBV

AbbVie

$98.79

0.6 (0.61%)

LYB

LyondellBasell

$113.07

1.155 (1.03%)

AVGO

Broadcom

$209.27

0.6 (0.29%)

RF

Regions Financial

$19.48

0.09 (0.46%)

SBUX

Starbucks

$53.58

0.53 (1.00%)

CF

CF Industries

$47.52

0.25 (0.53%)

MOS

Mosaic

$29.64

(0.00%)

NTR

Nutrien

$55.95

0.94 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 04

    Sep

  • 05

    Sep

  • 05

    Sep

  • 06

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Sep

  • 06

    Nov

VJET

voxeljet

$3.34

-0.17 (-4.84%)

19:14
08/19/18
08/19
19:14
08/19/18
19:14
Recommendations
voxeljet analyst commentary  »

voxeljet Q2 results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEG

Key Energy

$12.97

-0.03 (-0.23%)

18:30
08/19/18
08/19
18:30
08/19/18
18:30
Hot Stocks
Key Energy appoints Rob Saltiel as new President, CEO »

Key Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 02

    Oct

  • 03

    Oct

TWX

Acquired by T

$0.00

(0.00%)

, CMCSA

Comcast

$35.61

-0.05 (-0.14%)

16:52
08/19/18
08/19
16:52
08/19/18
16:52
Hot Stocks
Box Office Battle: 'Crazy Rich Asians' wins weekend with $25.2M debut »

Warner Bros. (TWX)…

TWX

Acquired by T

$0.00

(0.00%)

CMCSA

Comcast

$35.61

-0.05 (-0.14%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$54.88

1.055 (1.96%)

FOX

21st Century Fox

$44.83

-0.28 (-0.62%)

FOXA

21st Century Fox

$45.37

-0.34 (-0.74%)

LGF.A

Lionsgate

$22.95

-0.11 (-0.48%)

DIS

Disney

$112.44

-0.05 (-0.04%)

VIAB

Viacom

$30.72

0.62 (2.06%)

VIA

Viacom

$35.60

0.1 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

SHLD

Sears

$1.32

-0.135 (-9.28%)

12:28
08/19/18
08/19
12:28
08/19/18
12:28
Periodicals
Sears CEO wants board to sell him Kenmore, pay off debt, WSJ reports »

Sears CEO Edward Lampert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$97.89

-0.74 (-0.75%)

13:37
08/18/18
08/18
13:37
08/18/18
13:37
Periodicals
Walmart asks beauty suppliers to consider sourcing outside of China, Reuters say »

Walmart has asked some…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$0.00

(0.00%)

13:26
08/18/18
08/18
13:26
08/18/18
13:26
Periodicals
Tencent-backed Qutoutiao files for U.S. IPO, Reuters reports »

Chinese content…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$173.78

-0.98 (-0.56%)

, AMZN

Amazon.com

$1,881.94

-5.56 (-0.29%)

13:10
08/18/18
08/18
13:10
08/18/18
13:10
Periodicals
Selloff in Chinese internet stocks may shake faith in FANG, Reuters says »

A steep downturn in…

FB

Facebook

$173.78

-0.98 (-0.56%)

AMZN

Amazon.com

$1,881.94

-5.56 (-0.29%)

NFLX

Netflix

$316.78

-5.51 (-1.71%)

GOOG

Alphabet

$1,199.79

-6.21 (-0.51%)

GOOGL

Alphabet Class A

$1,215.50

-8.05 (-0.66%)

TCEHY

Tencent

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

  • 13

    Sep

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

VLKAY

Volkswagen

$0.00

(0.00%)

13:05
08/18/18
08/18
13:05
08/18/18
13:05
Periodicals
Volkswagen CEO was told about emissions software months before, Reuters reports »

Volkswagen CEO Herbert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$97.89

-0.74 (-0.75%)

, TCEHY

Tencent

$0.00

(0.00%)

13:01
08/18/18
08/18
13:01
08/18/18
13:01
Hot Stocks
Walmart, Flipkart announce completion of investment »

Walmart (WMT) and…

WMT

Walmart

$97.89

-0.74 (-0.75%)

TCEHY

Tencent

$0.00

(0.00%)

MSFT

Microsoft

$107.58

-0.07 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

BBOX

Black Box

$1.64

0.09 (5.81%)

12:57
08/18/18
08/18
12:57
08/18/18
12:57
Hot Stocks
Black Box announces sale agreement of Federal Government IT Services Business »

Black Box announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

$76.43

1.68 (2.25%)

12:52
08/18/18
08/18
12:52
08/18/18
12:52
Periodicals
Kohl's looking to break cycle, Barron's says »

Kohl's is set to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

STT

State Street

$84.95

0.73 (0.87%)

12:47
08/18/18
08/18
12:47
08/18/18
12:47
Periodicals
State Street selloff looks overdone, Barron's says »

At the moment, State…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$97.89

-0.74 (-0.75%)

, AMZN

Amazon.com

$1,881.94

-5.56 (-0.29%)

12:42
08/18/18
08/18
12:42
08/18/18
12:42
Periodicals
May be time to sell Walmart, Barron's says »

In a follow-up story,…

WMT

Walmart

$97.89

-0.74 (-0.75%)

AMZN

Amazon.com

$1,881.94

-5.56 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

VZ

Verizon

$54.79

0.51 (0.94%)

12:39
08/18/18
08/18
12:39
08/18/18
12:39
Periodicals
Verizon remains 'reasonably' priced, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CF

CF Industries

$47.52

0.25 (0.53%)

, MOS

Mosaic

$29.64

(0.00%)

12:36
08/18/18
08/18
12:36
08/18/18
12:36
Periodicals
CF, Mosaic gains have just begun, Barron's says »

CF Industries (CF),…

CF

CF Industries

$47.52

0.25 (0.53%)

MOS

Mosaic

$29.64

(0.00%)

NTR

Nutrien

$55.95

0.94 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 06

    Nov

ABBV

AbbVie

$98.79

0.6 (0.61%)

, LYB

LyondellBasell

$113.07

1.155 (1.03%)

12:25
08/18/18
08/18
12:25
08/18/18
12:25
Periodicals
StAbbVie, Starbucks among dividend standouts, Barron's says »

AbbVie (ABBV),…

ABBV

AbbVie

$98.79

0.6 (0.61%)

LYB

LyondellBasell

$113.07

1.155 (1.03%)

AVGO

Broadcom

$209.27

0.6 (0.29%)

RF

Regions Financial

$19.48

0.09 (0.46%)

SBUX

Starbucks

$53.58

0.53 (1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

  • 06

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Sep

BV

BrightView

$17.49

-0.06 (-0.34%)

12:21
08/18/18
08/18
12:21
08/18/18
12:21
Periodicals
Sunny outlook for BrightView, Barron's says »

BrightView's stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$42.26

1.15 (2.80%)

, CSIQ

Canadian Solar

$13.12

0.02 (0.15%)

11:18
08/18/18
08/18
11:18
08/18/18
11:18
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

HOG

Harley-Davidson

$42.26

1.15 (2.80%)

CSIQ

Canadian Solar

$13.12

0.02 (0.15%)

FSLR

First Solar

$50.98

0.18 (0.35%)

JASO

JA Solar

$0.00

(0.00%)

SUNEQ

SunEdison

$0.00

(0.00%)

SPWR

SunPower

$6.65

0.06 (0.91%)

TSL

Trina Solar

$0.00

(0.00%)

YGE

Yingli Green Energy

$0.00

(0.00%)

PEP

PepsiCo

$114.98

0.7 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

LYV

Live Nation

$48.15

-0.53 (-1.09%)

17:46
08/17/18
08/17
17:46
08/17/18
17:46
Hot Stocks
Live Nation CFO discloses sale of 40K shares of common stock »

Live Nation CFO Elizabeth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$72.63

0.21 (0.29%)

, XLU

Utilities SPDR

$54.50

0.25 (0.46%)

17:40
08/17/18
08/17
17:40
08/17/18
17:40
General news
Week ending ETF Scorecard: Consumer Staples outperforms, Energy skids »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$72.63

0.21 (0.29%)

XLU

Utilities SPDR

$54.50

0.25 (0.46%)

IYR

DJ US Real Estate Index Fund

$83.16

0.765 (0.93%)

XLP

Consumer Staples Sector SPDR

$55.02

0.39 (0.71%)

XLY

Consumer Discretionary Sector SPDR

$112.51

0.11 (0.10%)

XLB

S&P Select Materials SPDR

$58.41

0.41 (0.71%)

XLF

Financial Select Sector

$28.16

0.055 (0.20%)

XLV

Health Care Select Sector SPDR

$91.12

0.33 (0.36%)

XLK

Technology Select Sector SPDR

$73.17

0.14 (0.19%)

XLI

Industrial Select Sector SPDR

$76.26

0.47 (0.62%)

GLD

SPDR Gold Trust

$112.12

1.01 (0.91%)

SLV

iShares Silver Trust

$13.93

0.16 (1.16%)

USO

United States Oil Fund

$13.70

0.065 (0.48%)

UNG

United States Natural Gas Fund

$24.18

0.295 (1.24%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.03

0.08 (0.09%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.97

0.11 (0.09%)

TLT

iShares 20+ Year Treasury Bond Fund

$120.99

0.16 (0.13%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.49

0.04 (0.04%)

SHY

iShares 1-3 Year Treasury Bond

$83.28

0.03 (0.04%)

IWD

iShares Russell 1000 Value

$126.16

0.6 (0.48%)

IWF

iShares Russell 1000 Growth

$150.80

0.27 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$112.12

1.01 (0.91%)

17:33
08/17/18
08/17
17:33
08/17/18
17:33
Hot Stocks
SPDR Gold Trust holdings fall to 772.24MT from 773.41MT »

This is the 5th…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDOT

Green Dot

$85.04

0.37 (0.44%)

17:30
08/17/18
08/17
17:30
08/17/18
17:30
Hot Stocks
Green Dot exec Dent sells 7,754 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SMSI

Smith Micro

$2.49

-0.01 (-0.40%)

17:17
08/17/18
08/17
17:17
08/17/18
17:17
Syndicate
Breaking Syndicate news story on Smith Micro »

Smith Micro files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDRA

ENDRA Life Sciences

$2.70

0.2 (8.00%)

17:14
08/17/18
08/17
17:14
08/17/18
17:14
Syndicate
Breaking Syndicate news story on ENDRA Life Sciences »

ENDRA Life Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.